These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 6150639)

  • 1. Histamine H2-antagonist drug interactions in perspective: mechanistic concepts and clinical implications.
    Powell JR; Donn KH
    Am J Med; 1984 Nov; 77(5B):57-84. PubMed ID: 6150639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetic basis for H2-antagonist drug interactions: concepts and implications.
    Powell JR; Donn KH
    J Clin Gastroenterol; 1983; 5 Suppl 1():95-113. PubMed ID: 6140286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the safety profile of the H2-receptor antagonists.
    Hansten PD
    DICP; 1990 Nov; 24(11 Suppl):S38-41. PubMed ID: 1980183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of H2-receptor antagonists on drug interaction in rats.
    Lin JH; Cocchetto DM; Yeh KC; Duggan DE
    Drug Metab Dispos; 1986; 14(6):649-53. PubMed ID: 2877821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug interactions of H2-receptor antagonists involving cytochrome P450 (CYPs) enzymes: from the laboratory to the clinic.
    Rendić S
    Croat Med J; 1999 Sep; 40(3):357-67. PubMed ID: 10411963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug metabolism by rat and human hepatic microsomes in response to interaction with H2-receptor antagonists.
    Knodell RG; Holtzman JL; Crankshaw DL; Steele NM; Stanley LN
    Gastroenterology; 1982 Jan; 82(1):84-8. PubMed ID: 6118314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of theophylline and the H2-antagonist drugs cimetidine and ranitidine.
    Dal Negro R; Pomari C; Zoccatelli O; Trevisan F; Carloni C; Turco P
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):221-6. PubMed ID: 6325354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions and non-interactions with ranitidine.
    Kirch W; Hoensch H; Janisch HD
    Clin Pharmacokinet; 1984; 9(6):493-510. PubMed ID: 6096071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of H2 antagonists on the differential secretion of triamterene and its sulfate conjugate metabolite by the isolated perfused rat kidney.
    Muirhead MR; Somogyi AA
    Drug Metab Dispos; 1991; 19(2):312-6. PubMed ID: 1676629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists.
    Martínez C; Albet C; Agúndez JA; Herrero E; Carrillo JA; Márquez M; Benítez J; Ortiz JA
    Clin Pharmacol Ther; 1999 Apr; 65(4):369-76. PubMed ID: 10223772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of H2-receptor antagonists on steady-state extraction of indocyanine green and lidocaine by the perfused rat liver.
    Roberts RK; Heath CA; Johnson RF; Speeg KV; Schenker S
    J Lab Clin Med; 1986 Feb; 107(2):112-7. PubMed ID: 2868064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of histamine H2-receptor antagonists on the hepatic elimination of drugs].
    Klotz U; Reimann I
    Klin Wochenschr; 1983 Jul; 61(13):625-32. PubMed ID: 6136626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interaction between drugs. A critical assessment of various controlling factors in relation to clinical significance--exemplified by cimetidine].
    Elwin CE
    Nord Med; 1991; 106(5):151-4, 167. PubMed ID: 1675459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.
    Mück W; Ritter W; Dietrich H; Frey R; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):261-4. PubMed ID: 9208343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier-mediated active transport of histamine H2 receptor antagonists, cimetidine and nizatidine, into isolated rat hepatocytes: contribution of type I system.
    Nakamura H; Sano H; Yamazaki M; Sugiyama Y
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1220-7. PubMed ID: 7912279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cimetidine or ranitidine in renal transplant patients receiving cyclosporine.
    Barri YM; Ramos EL; Balagtas RS; Peterson JC; Karlix JL
    Clin Transplant; 1996 Feb; 10(1 Pt 1):34-8. PubMed ID: 8652895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic drug interactions between triamterene and ranitidine in humans: alterations in renal and hepatic clearances and gastrointestinal absorption.
    Muirhead M; Bochner F; Somogyi A
    J Pharmacol Exp Ther; 1988 Feb; 244(2):734-9. PubMed ID: 3346844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection by cimetidine, but not ranitidine, implies that H2 receptors do not mediate arrhythmogenesis in a rat model of regional ischaemia and reperfusion in vitro.
    Banning MM; Curtis MJ
    Cardiovasc Res; 1995 Nov; 30(5):705-10. PubMed ID: 8595616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dosage alternative for H2-receptor antagonists--constant infusion.
    Siepler JK
    Clin Ther; 1986; 8 Suppl A():24-33. PubMed ID: 2878728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selectivity of the cimetidine-induced alterations in the renal handling of organic substrates in humans. Studies with anionic, cationic and zwitterionic drugs.
    van Crugten J; Bochner F; Keal J; Somogyi A
    J Pharmacol Exp Ther; 1986 Feb; 236(2):481-7. PubMed ID: 3944769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.